Laboratory features at the time of diagnosis and clinical features in patients with RA classified according to the FAB criteria
. | Japan, n = 131 . | Germany, n = 597 . | P . |
|---|---|---|---|
| Sex, male/female | 70/61 | 309/288 | .73 |
| Age, y | 57 (12-88) | 71 (7-93) | < .001 |
| Neutrophil count, × 109/L | 1.58 (0.05-10.24) | 1.98 (0.06-23.00) | < .001 |
| Hemoglobin concentration, g/L | 84 (25-143) | 94 (30-169) | .002 |
| Platelet count, × 109/L | 41 (4-390) | 127 (2-1540) | < .001 |
| 2- or 3-lineage cytopenias, %* | 68 | 39 | < .001 |
| Abnormal karyotype, % | 29 | 53 | < .001 |
| Median survival, mo | 175 | 40 | < .001 |
. | Japan, n = 131 . | Germany, n = 597 . | P . |
|---|---|---|---|
| Sex, male/female | 70/61 | 309/288 | .73 |
| Age, y | 57 (12-88) | 71 (7-93) | < .001 |
| Neutrophil count, × 109/L | 1.58 (0.05-10.24) | 1.98 (0.06-23.00) | < .001 |
| Hemoglobin concentration, g/L | 84 (25-143) | 94 (30-169) | .002 |
| Platelet count, × 109/L | 41 (4-390) | 127 (2-1540) | < .001 |
| 2- or 3-lineage cytopenias, %* | 68 | 39 | < .001 |
| Abnormal karyotype, % | 29 | 53 | < .001 |
| Median survival, mo | 175 | 40 | < .001 |
Values for presentation characteristics are given as median and range (in parentheses) where applicable.
Cytopenia according to IPSS: hemoglobin concentration less than 100 g/L, absolute neutrophil count less than 1.5 × 109/L, platelet count less than 100 × 109/L.